New pancreatic cancer drug shows promise in trial

Name: New pancreatic cancer drug shows promise in trial
Uploaded: 2026-04-16T17:34:38Z
Duration: 6 min 52 s

FOX LOCAL San Francisco · Apr 16, 2026 · 6m 52s

Sign Up Now

Already a subscriber?

A Redwood City-based company says its new pancreatic cancer drug could significantly improve survival rates after a successful phase 3 trial. Revolution Medicines reports daraxonrasib nearly doubled survival time and reduced the risk of death by 60% compared to chemotherapy. Dr. Brandon Huffman, a gastrointestinal oncologist from Dana-Farber Cancer Institute, joined us on 'The Nine' to discuss what this could mean for patients.